...
首页> 外文期刊>CardioVascular and Interventional Radiology >Observation of Intravascular Changes of Superabsorbent Polymer Microsphere (SAP-MS) with Monochromatic X-Ray Imaging
【24h】

Observation of Intravascular Changes of Superabsorbent Polymer Microsphere (SAP-MS) with Monochromatic X-Ray Imaging

机译:单色X射线成像观察超吸收性聚合物微球(SAP-MS)的血管内变化

获取原文
获取原文并翻译 | 示例
           

摘要

This study was designed to evaluate the intravascular transformation behavior of superabsorbent polymer microsphere (SAP-MS) in vivo macroscopically by using monochromatic X-ray imaging and to quantitatively compare the expansion rate of SAP-MS among different kinds of mixtures. Fifteen rabbits were used for our study and transcatheter arterial embolization (TAE) was performed for their auricular arteries using monochromatic X-ray imaging. We used three kinds of SAP-MS (particle diameter 100–150 μm) mixture as embolic spherical particles: SAP-MS(H) absorbed with sodium meglumine ioxaglate (Hexabrix 320®), SAP-MS(V) absorbed with isosmolar contrast medium (Visipaque 270®), and SAP-MS(S) absorbed with 0.9% sodium saline. The initial volume of SAP-MS particles just after TAE and its final volume 10 minutes after TAE in the vessel were measured to calculate the expansion rate (ER) (n = 30). Intravascular behavior of SAP-MS particles was clearly observed in real time at monochromatic X-ray imaging. Averaged initial volumes of SAP-MS (H) (1.24 × 107 μm3) were significantly smaller (p < 0.001) than those of SAP-MS (V) (5.99 × 107 μm3) and SAP-MS (S) (5.85 × 107 μm3). Averaged final volumes of SAP-MS (H) were significantly larger than averaged initial volumes (4.41 × 107 μm3 vs. 1.24 × 107 μm3; p < 0.0001, ER = 3.55). There were no significant difference between averaged final volumes and averaged initial volumes of SAP-MS (V) and SAP-MS (S). SAP-MS (H), which first travels distally, reaches to small arteries, and then expands to adapt to the vessel lumen, is an effective particle as an embolic agent, causing effective embolization.
机译:本研究旨在通过单色X射线成像宏观评估超吸收性聚合物微球(SAP-MS)在体内的血管内转化行为,并定量比较SAP-MS在不同种类混合物中的膨胀率。 15只兔子用于我们的研究,并且使用单色X射线成像技术对他们的耳动脉进行经导管动脉栓塞(TAE)。我们使用三种类型的SAP-MS(粒径100-150μm)混合物作为栓塞球形颗粒:甲磺酸葡糖胺(Hexabrix 320 ®)吸收的SAP-MS(H),SAP-MS( V)用等渗造影剂(Visipaque 270 ®)吸收,SAP-MS(S)用0.9%的钠盐吸收。测量刚好在TAE之后的SAP-MS颗粒的初始体积和在TAE之后10分钟的容器中的最终体积,以计算膨胀率(ER)(n = 30)。在单色X射线成像中实时清晰地观察到SAP-MS颗粒的血管内行为。 SAP-MS(H)的平均初始体积(1.24×10 7 μm 3 )显着小于(p <0.001)(V)( 5.99×10 7 μm 3 )和SAP-MS(S)(5.85×10 7 μm 3 ) 。 SAP-MS的平均最终体积(H)明显大于平均初始体积(4.41×10 7 μm 3 与1.24×10 7 μm 3 ; p <0.0001,ER = 3.55)。 SAP-MS(V)和SAP-MS(S)的平均最终体积与平均初始体积之间没有显着差异。 SAP-MS(H)首先向远端移动,到达小动脉,然后膨胀以适应血管腔,是一种有效的颗粒,可作为栓塞剂,引起有效的栓塞。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号